141 related articles for article (PubMed ID: 7947266)
1. Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma.
Witzig TE; Kyle RA; O'Fallon WM; Greipp PR
Br J Haematol; 1994 Jun; 87(2):266-72. PubMed ID: 7947266
[TBL] [Abstract][Full Text] [Related]
2. A contribution to examination of propidium iodide and annexin V plasma cells indices in multiple myeloma.
Scudla V; Ordeltova M; Bacovsky J; Vytrasova M; Sumna E; Martinek A; Horak P
Neoplasma; 2003; 50(5):363-71. PubMed ID: 14628090
[TBL] [Abstract][Full Text] [Related]
3. Enumeration and characterization of circulating multiple myeloma cells in patients with plasma cell disorders.
Foulk B; Schaffer M; Gross S; Rao C; Smirnov D; Connelly MC; Chaturvedi S; Reddy M; Brittingham G; Mata M; Repollet M; Rojas C; Auclair D; DeRome M; ; Weiss B; Sasser AK
Br J Haematol; 2018 Jan; 180(1):71-81. PubMed ID: 29105742
[TBL] [Abstract][Full Text] [Related]
4. Involvement of peripheral blood cells in multiple myeloma: chromosome changes are the rule within circulating plasma cells but not within B lymphocytes.
Zandecki M; Bernardi F; Genevieve F; Laï JL; Preudhomme C; Flactif M; Cosson A; Bauters F; Facon T
Leukemia; 1997 Jul; 11(7):1034-9. PubMed ID: 9204987
[TBL] [Abstract][Full Text] [Related]
5. Multiple myeloma: the number of reinfused plasma cells does not influence outcome of patients treated with intensified chemotherapy and PBPC support.
Boccadoro M; Omedé P; Dominietto A; Palumbo A; Bringhen S; Giaretta F; Ortolano B; Triolo S; Pileri A
Bone Marrow Transplant; 2000 Jan; 25(1):25-9. PubMed ID: 10654010
[TBL] [Abstract][Full Text] [Related]
6. Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen.
Schneider U; van Lessen A; Huhn D; Serke S
Br J Haematol; 1997 Apr; 97(1):56-64. PubMed ID: 9136942
[TBL] [Abstract][Full Text] [Related]
7. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
Kloth JK; Hillengass J; Listl K; Kilk K; Hielscher T; Landgren O; Delorme S; Goldschmidt H; Kauczor HU; Weber MA
Int J Cancer; 2014 Nov; 135(10):2380-6. PubMed ID: 24706394
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma.
Witzig TE; Gertz MA; Lust JA; Kyle RA; O'Fallon WM; Greipp PR
Blood; 1996 Sep; 88(5):1780-7. PubMed ID: 8781435
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors associated with progression of smoldering multiple myeloma to symptomatic form.
Rago A; Grammatico S; Za T; Levi A; Mecarocci S; Siniscalchi A; De Rosa L; Felici S; Bongarzoni V; Piccioni AL; La Verde G; Pisani F; Franceschini L; Paviglianiti AL; Caravita T; Petrucci MT; De Stefano V; Cimino G;
Cancer; 2012 Nov; 118(22):5544-9. PubMed ID: 22786730
[TBL] [Abstract][Full Text] [Related]
10. Circulating peripheral blood plasma cells as a prognostic indicator in patients with primary systemic amyloidosis.
Pardanani A; Witzig TE; Schroeder G; McElroy EA; Fonseca R; Dispenzieri A; Lacy MQ; Lust JA; Kyle RA; Greipp PR; Gertz MA; Rajkumar SV
Blood; 2003 Feb; 101(3):827-30. PubMed ID: 12393530
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal gammopathy and smoldering multiple myeloma: diagnosis, staging, prognosis, management.
Hillengass J; Moehler T; Hundemer M
Recent Results Cancer Res; 2011; 183():113-31. PubMed ID: 21509683
[TBL] [Abstract][Full Text] [Related]
12. Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts.
Vescio RA; Han EJ; Schiller GJ; Lee JC; Wu CH; Cao J; Shin J; Kim A; Lichtenstein AK; Berenson JR
Bone Marrow Transplant; 1996 Jul; 18(1):103-10. PubMed ID: 8832002
[TBL] [Abstract][Full Text] [Related]
13. Cell proliferation of myeloma plasma cells: comparison of the blood and marrow compartments.
Kumar S; Rajkumar SV; Greipp PR; Witzig TE
Am J Hematol; 2004 Sep; 77(1):7-11. PubMed ID: 15307099
[TBL] [Abstract][Full Text] [Related]
14. High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma.
Bianchi G; Kyle RA; Larson DR; Witzig TE; Kumar S; Dispenzieri A; Morice WG; Rajkumar SV
Leukemia; 2013 Mar; 27(3):680-5. PubMed ID: 22902364
[TBL] [Abstract][Full Text] [Related]
15. Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells.
Pérez-Persona E; Mateo G; García-Sanz R; Mateos MV; de Las Heras N; de Coca AG; Hernández JM; Galende J; Martín-Nuñez G; Bárez A; Alonso JM; Martín A; López-Berges C; Orfao A; San Miguel JF; Vidriales MB
Br J Haematol; 2010 Jan; 148(1):110-4. PubMed ID: 19821821
[TBL] [Abstract][Full Text] [Related]
16. [Detection of circulating and bone marrow myeloma cells in patients with multiple myeloma and its clinical significance].
Jiang YQ; Li JY; Wu YJ; Yang H; Shen YF; Chen LJ; Xu W; Qian SX; Wu HX; Lu H; Shen RL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):908-12. PubMed ID: 17096887
[TBL] [Abstract][Full Text] [Related]
17. Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy.
Boccadoro M; Gavarotti P; Fossati G; Pileri A; Marmont F; Neretto G; Gallamini A; Volta C; Tribalto M; Testa MG
Br J Haematol; 1984 Dec; 58(4):689-96. PubMed ID: 6518137
[TBL] [Abstract][Full Text] [Related]
18. Smoldering multiple myeloma.
Gao M; Yang G; Kong Y; Wu X; Shi J
Biomed Res Int; 2015; 2015():623254. PubMed ID: 26000300
[TBL] [Abstract][Full Text] [Related]
19. Plasma cell morphology in multiple myeloma and related disorders.
Ribourtout B; Zandecki M
Morphologie; 2015 Jun; 99(325):38-62. PubMed ID: 25899140
[TBL] [Abstract][Full Text] [Related]
20. Measurement of apoptosis and proliferation of bone marrow plasma cells in patients with plasma cell proliferative disorders.
Witzig TE; Timm M; Larson D; Therneau T; Greipp PR
Br J Haematol; 1999 Jan; 104(1):131-7. PubMed ID: 10027725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
